Absci ABSI
NASDAQ ABSI
$8.82 +0.02 (+0.23%)
As of: Sep 4, 2026 · 3:59 PM EDT

Absci (ABSI) Net Cash Flow (2020 - 2026)

Absci (ABSI) posted Net Cash Flow of -$11.4 million for Q1 2026, down 96.6% sequentially from -$5.8 million in Q4 2025, and down 292.67% YoY from $5.9 million in Q1 2025.

Analysis

Absci (ABSI) Net Cash Flow (2020 - 2026) Analysis & Trends

Absci has reported Net Cash Flow for 7 years, with the latest figure at -$11.4 million in Q1 2026.

  • Quarterly Net Cash Flow fell 292.67% year-over-year to -$11.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$54.4 million (down 346.86% YoY) and the FY2025 annual result came in at -$37.1 million, down 18.07% from the prior year.
  • Net Cash Flow slipped to -$11.4 million in Q1 2026 per ABSI's latest filing, from -$5.8 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $49.7 million in Q2 2023 and troughed at -$98.7 million in Q3 2022.
  • A 5-year average of -$15.9 million and a median of -$11.4 million in 2026 frame the typical range for Net Cash Flow.
  • The sharpest annual moves came in 2023 and 2025: Net Cash Flow surged 277.63% in 2023, then plunged 422.74% in 2025.
  • Over 5 years, Net Cash Flow stood at -$47.4 million in 2022, then soared by 105.92% to $2.8 million in 2023, then grew by 9.43% to $3.1 million in 2024, then tumbled by 289.0% to -$5.8 million in 2025, then sank by 96.6% to -$11.4 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods registered -$11.4 million, -$5.8 million, and -$28.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 652.90 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -504.30 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -183.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 374.50 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 407.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -496,000.00
8 Royalty Pharma 28.45 Bn 27.61 Bn - 225.59 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -37.14 Mn
10 Absci 1.39 Bn 1.19 Bn - 99.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 99.23 Mn
Mar 31, 2026 -11.39 Mn
Dec 31, 2025 -5.79 Mn
Sep 30, 2025 -28.42 Mn
Jun 30, 2025 -8.84 Mn
Mar 31, 2025 5.91 Mn
Dec 31, 2024 3.07 Mn
Sep 30, 2024 -5.44 Mn
Jun 30, 2024 -15.72 Mn
Mar 31, 2024 -13.36 Mn
Dec 31, 2023 2.80 Mn
Sep 30, 2023 8.85 Mn
Jun 30, 2023 49.70 Mn
Mar 31, 2023 -48.52 Mn
Dec 31, 2022 -47.35 Mn
Sep 30, 2022 -98.69 Mn
Jun 30, 2022 -27.98 Mn
Mar 31, 2022 -29.06 Mn
Dec 31, 2021 -26.69 Mn
Sep 30, 2021 179.82 Mn